OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $251,021 Invested

2021

C. Light Technologies, Inc.

Christy Sheehy, PhD

Fixational eye motion as biomarker for mild cognitive impairment

  • Funding Amount: $251,021
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Status: Active